A new concept in antibiotic therapy


Azithromycin, a broad-spectrum antibiotic belonging to the macrolide group, acts on Gram+, Gram- and Anaerobic bacteria, intracellular microorganisms such as Chlamydias and Mycoplasmas, and also against Protozoa such as Coccidia and Toxoplasmas. Its pharmacokinetics stand out for excellent oral absorption and rapid bioavailability, reaching high concentration in tissues, at the infection site and at the intracellular level. Moreover, it is eliminated as an active antibiotic via bile, feces and urine. Its great post-antibiotic effect allows for short and effective therapies.

Indicated for use in dogs and cats.


Each tablet contains:
Azithromycin base 200 mg
Excipients q.s. 415 mg


  • To treat infections caused by azithromycin-sensitive germs in: high and low respiratory tract diseases, dermatological, genitourinary, digestive and osteoarticular diseases.
  • Especially indicated for oral infections (gingivitis, periodontitis, etc.), as well as for pre- and post-surgical prophylaxis associated with dental cleaning.
  • Coccidiosis and Toxoplasmosis.

Dosage and Administration Routes:

Oral administration.
  • General Dosage: 10 to 20 mg/kg of body weight (1 tablet every 10 to 20 kg) every 24 hours for 3 consecutive days. In deep pyoderma, treatments exceeding 15 days are recommended.
  • Dose for coccidia: one dose of 30 mg/kg of body weight is recommended, repeat after 3 days. A third dose may be applied as a booster.
Pack - Azithromycin
This presentation corresponds to the Global portfolio, it may vary according to your country of residence.